Although
homogeneous detection of some biomolecules has been of
great significance in clinical assay, it faces great challenges in
achieving precise in situ imaging of biomolecules.
In addition, nonspecific adsorption between probes and biomolecules
and low sensitivity are still unfathomed problems. Herein, we developed
a promoted “Click” surface enhanced Raman scattering
(SERS) strategy for realizing highly selective homogeneous detection
of biomolecules by simultaneous dual enhanced SERS emissions, obtaining
mutually confirmed logical judgment. Taking caspase-3 as one of the
biotargets, we have realized highly selective homogeneous detection
of caspase-3 using this strategy, and precise intracellular imaging
of caspase-3 can be in situ monitored in living cells
or during cell apoptosis. In detail, polyA-DNA and the Asp-Glu-Val-Asp
(DEVD)-containing peptide sequence were modified into alkyne and nitrile-coded
Au nanoparticles (NPs). During the cell apoptosis process, the generated
caspase-3 would lead to the cleavage of the tetra-peptide sequence
DEVD, thereby removing the negative protection part from the peptide
on Au NPs. Interestingly, two different triple bond-labeled Au NPs
can be connected together through DNA hybridization to form SERS “hotspot”,
resulting in simultaneously enlarged triple bond Raman signals. Moreover,
we found that the SERS intensity was positively related with caspase-3
concentration, which has a wide linear range (0.1 ng/mL to 10 μg/mL)
and low detection limit (7.18 × 10–2 ng/mL).
Remarkably, these simultaneously enlarged signals by “Click”
SERS could be used for more precise imaging of caspase-3, providing
mutually confirmed logical judgment based on two spliced SERS emissions,
especially for their relative intensity.